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Mining Drug Properties for Decision Support in
Dental Clinics
Abstract. With poly-pharmacy becoming more common, it is impor-
tant for health providers to be aware of the drug profile of patients before
prescribing. Although there are many methods on extracting information
on drug interactions, they do not integrate with the patients’ medical his-
tory. This paper describes state-of-the art approaches in extracting the
term frequencies of drug properties, and using this knowledge to decide
if a drug is suitable for prescription after considering if there is any drug
allergy the patient may have and the drugs that the patient is currently
taking. An experiment is conducted to evaluate the accuracy of associat-
ing the similarity ratio in terms of their term frequencies to the similarity
between them. Experimental evaluation of our model yields an accuracy
of over 80% which is superior to models that use other methods. Since a
drug is to be avoided if it is similar to a drug that patient is allergic to,
our model will help dentist decide if a drug is suitable for prescription to
the patient. Hence such an approach, when integrated within the clini-
cal workflow will reduce prescription errors thereby increasing the health
outcome of the patients.
Keywords: adverse relationship; drug allergy; drug properties; knowledge-
base; personalised prescription; similarity ratio; term frequency
1 Introduction
With the increased in volume and complexity of data encountered by dentists,
the use of decision support systems to help in their decision making is becoming
more of a necessity than a luxury. In order for decision support systems to be
readily accepted by dentists, they should have, among other features, the ability
to provide assistance on drug prescription based on individual patient profile [6].
In fact, predicting drug interactions at point-of-care to reduce prescription
error is important as an adverse event can lead to serious health consequences for
the patients and resulting in expensive legal suits for the practitioners. One of the
cause for hospital admissions worldwide is adverse drug reaction and incidence
of such hospitalised patients can be as high as 24% [12]. Naturally, many such
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admissions could have been avoided if more care are taken in the prescription of
medicine by considering possible drug allergy the patient may have.
So far many methods have been developed with the aim of extracting infor-
mation on drug interactions [3,4]. A recent work by [2] has developed a literature-
based system to find out the similarity of a drug pair. However, unfortunately
these methods do not integrate with the patients medical history within the
clinical workflow of the clinic.
With this motivation in mind, this paper describes state-of-the-art approaches
in determining if a drug pair is similar as well as using such information to sup-
port the prescription decision of the dentist. In this study, we proposed a three-
tier conceptual framework - knowledge layer, data layer and user layer. Data
mining is performed within the data layer, with knowledge extracted from the
knowledge layer and presented to the user layer for decision making. The unique
approach in our model is in the way the relationship of a drug pair is associated
with the properties of the drug pair.
As with many decision support systems that are developed based on knowl-
edge discovered from data mining [15], this paper describes a model which com-
putes the similarity within a drug pair for predicting its suitability before the
dentist prescribes it to the patient.
By using neighborhood similarities and textual data from currently avail-
able open source datasets to predict the relationship of a drug pair, knowledge
obtained from data mining is used for prescription support of health care pro-
fessionals. Based on a novel data-driven text mining technique, clusters of drugs
which have adverse interactions are collected, together with their properties, by
identifying their field markers from the web content. This information allows
a similarity ratio to be computed which indicates if a drug pair can be safely
prescribed to the patient.
Our work performs well compared to other methods of prediction, with a
F measure of 64% with drug properties gathered from textual data obtained
through bio medical sources. The model in this paper can be easily utilised in
predicting if a drug pair is suitable for prescription, by considering the existing
drugs that the patient is taking to avoid adverse interactions and also the drug
allergies the patient may have to avoid cross allergy.
This study will help provide strategies in research agenda and priorities such
as methodologies for knowledge reasoning and inference in the context of a den-
tal clinic. Research outcome of this project will help dentists reduce potential
risk of issuing allergic drugs to a patient and as a result, improve the quality of
treatment in clinics. The advice on adverse drug reaction is increasingly impor-
tant especially with an increased probability of an adverse interaction given the
increasing use of multiple medications among patients.
This system which delivers information on interacting drug pairs based on
the patients drug profile will also benefit those who are involved in clinical edu-
cation relating to drug dispensing, such as in medicine, nursing and pharmacy.
The practical use of data mining techniques in supporting the dentists prescrip-
tion of drugs will has great potential to extend to the wider medical domain,
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since there is also a need for doctors to ensure the safe prescription of drugs to
patients. Our work will make significant contribution to the transformation of
current health care industry to evidence-based, personalised health care, since
patients individual conditions are considered in decision-making support within
the clinical workflow.
The rest of paper is organised as follows: Section 2 discusses the related work
in data mining and how model differs in the way drug-relationship is detected
and deployed for use. Section 3 introduces the framework of our model and
Section 4 outlines the parameters used for evaluating our work. This is followed
by Section 5 where the results are discussed and compared with other approaches
and Section 6 presents the conclusions obtained.
2 Related Work
Many systems have been developed using data mining techniques to explore
drug interactions. In fact, such techniques are evolving quickly to improve the
accuracy of the experiments, though in most situations results may not be suffi-
cient to derive Drug Drug Interactions (DDI) [17]. A recent work by [1] attempt
to determine DDI by identifying neutral candidates, negation cues and scopes
from bio-medical articles. Features extracted from these articles include linguis-
tic definition of negation, the position of the drugs discussed in the sentence and
the linguistic-based confident level of an interaction. By using data sets from
drug bank, it is reported that the results achieved an F measure of 68.4%. Text
mining techniques are also recently used to predict protein interaction from bio
medical literature [11].
Another common way of examining drug interactions is to extract relevant
information from text. For example, [16] has developed a method that combines
text mining and automated reasoning to predict enzyme- specific DDIs. [18] also
uses text mining techniques to create features based on relevant information such
as genes and disease names extracted from drug databases to augment limited
domain knowledge. These features are then used to build a logistic regression
model to predict drug-drug interaction (DDI).
Another study to extract information on drug-drug interactions (DDI) from
biomedical text was proposed by Bui et al. [3]. DDI pairs are mapped according
to their syntactic structure followed by the generation of feature vectors for these
DDI pairs. These feature vectors are then used for the generation of a predictive
model which classify the drug pair as interacting or not interacting [3].
Though these studies use data mining methods to extract relevant informa-
tion for the prediction of drug interaction, unfortunately, these works only con-
fine to the knowledge layer and data computing layer as outline in the three-tier
framework in this paper.
The crucial need of using the knowledge obtained from data mining moti-
vates us to develop the three-tier conceptual framework proposed in this paper.
Although our system is similar to that proposed by [4] in terms of using informa-
tion from the patient, the unique approach adopted in this paper goes one step
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further in using such information to support the decision making process for the
dentist at point-of-care within the clinical workflow of the dental clinic. In this
model, an additional user layer is introduced. This layer provides an important
interface between the user and knowledge mined from bio medical data sources.
Moreover, state-of-the-art approach adopted in the data layer allows the efficient
extraction of features. These features relate the similarity of a drug pair in terms
of the shared difference in their term frequencies. Experiment results show that
this approach performs favorably compared to other existing models.
3 Proposed Method
The aim of this study is to propose an unique approach in supporting the dentist
in drug prescription taking into account the drug that patient is currently taking
and the drug that the patient is allergic to. In order to advise the dentist if the
drug to be prescribed is suitable, a three-tier conceptual model is used. These
layers are the knowledge layer, data computing layer and user layer (Figure 1).
Essentially, each layer is defined by the task that they are responsible for. At
each layer, data is transformed and processed which culminate as an advice to
the dentist if the drug is safe for prescription and to suggest an alternative drug.
3.1 Knowledge Layer
Many decision support systems depend on information retrieved from the web for
further processing and inference-making to arrive at a decision [5]. In this layer,
a taxonomy of drugs will be generated using information gathered from the web
with expert domain knowledge. The publicly available website http://www.drugs.com
contains independent and accurate information on more than 24,000 prescription
drugs pertaining to interactions, dosages and other important information for
both patients and professionals. It is maintained in collaboration with the US
Food and Drug Administration (FDA), which acknowledges that such partner-
ships “are part of FDAs effort to ensure the public has easy access to reliable,
useful information that can help people protect and improve their health”1. Each
drug is being described from a different perspective to suit both patients and
health professionals. These are contained under the heading “Overview” and
“Professional” for each drug. Information on side effects are also found under
the heading “Side Effects”. In this study, term frequencies from each of these
descriptions are extracted so that similarity ratio can be computed. Essentially,
this layer consists of the term frequencies of each drug within the drug taxonomy
T for the respective drug properties described under the headings “Overview”,
“Professional” and “Side Effects”.
Definition 1. – [Drug Taxonomy]
Let T be the conceptual taxonomy of all drugs. T consists of the domain of drugs
linked by their semantic relations of advantageous and adverse, and is defined
as a 3-tuple T := 〈D,R,HRD〉, where
1 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm212844.htm
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Fig. 1. Three-tier framework
Fig. 2. Subset of Drug Taxonomy
– D = {d1, d2, ..., d|D|} is the domain set of drugs;
– R = {r−, r0} is a set of semantic relations, where r−(di, dj) means that the
effects of drugs di and dj are adverse; r
0(di, dj) means that the effects of
drugs di and dj are not defined.
– HRD is the taxonomical structure constructed by all d ∈ D linked by r ∈ R.
Definition 2. – [Drug Properties]
The three properties associated with each drug will have their set of term frequen-
cies. Let D be the set of drugs in drugbank, tv be the set of terms in “Overview”,
tp be the set of terms in “Professional” and ts be the set of terms in “Side Ef-
fects”
Then
term frequency in Overview tfv = {di, {tv1 , tv2 , ....tvn}} where di ∈ D
term frequency in Professional tfp = {di, {tp1 , tp2 , ....tpn}} where di ∈ D
term frequency in Side Effect tfs = {di, {ts1 , ts2 , ....tsn}} where di ∈ D
The ability to store interactive drug pairs within a network of nodes and edges
allows the knowledge layer to be represented by a directed acyclic graph (DAG).
Each drug is represented as a vertex on the graph. The edges that connect
a pair of vertices show the interactions between the drug pair. The cluster of
drugs that has adverse interactions with a given drug can be known from the
drug taxonomy. Since this project aims to find the similarity between a drug pair
based on the term frequencies of each drug, the DAG allows such information to
be obtained efficiently by having an algorithm to traverse through the network
for the existence of the drug pair. Moreover, features of the drugs stored within
each node of the DAG contributes to the Data Layer for mining the properties
in terms of their term frequencies (see next section).
Figure 2 shows a subset of the major drug interactions in the drug taxonomy.
Note that nodes in the taxonomy are connected to one another through arrows
which shows that they have an adverse relationship, as the drug pair has adverse
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interaction. Each node on the drug taxonomy will consists of a drug with its
associated properties. Such a chain of drug interactions will form the backbone
of the drug DAG. As shown in Figure 2, capreomycin has adverse interactions
with adefvoir and tenofovir, which in turn interacts respectively with ibuprofen
and caffeine. However, ibuprofen and caffeine are also in an adverse relationship,
which shows that a given drug may interact adversely with more than one drug.
3.2 Mining Properties
In this paper, we are only interested in the content in terms of properties of
each drug within the drug taxonomy T . This will enable us to compute the sim-
ilarity of their term frequencies. Such properties of the drugs are obtained from
the content provided under “Professional”, “Side Effects” and “Overview”. To
determine the similarity within a drug pair, information on the term frequencies
of each drug are collected.
Given the numerous techniques and algorithms available in data mining [13],
the approach adopted in this layer is focused on speed and accuracy with easy
interfacing between the knowledge layer and the user layer. Thus, at this layer,
the properties associated with the drugs residing on the drug taxonomy back-
bone are mined, namely the term frequencies tfv, tfp and tfs respectively for
“Overview”, “Professional” and “Side Effects”. Before term frequencies and doc-
ument frequencies are computed from the properties of the drug, data is pre-
processed. This is also a common practice where pre-processing is applied before
any mining techniques are used on the text [10] which includes stop word removal
and stemming. The idea behind our novel approach is to use the similarity ratio
between the feature vectors of term frequencies to decide if the drug pair is sim-
ilar, and using this knowledge to advise dentist if it is suitable for prescription,
taking into consideration the individual medical status of the patient.
Thus the data layer should aim to reduce the content of the relevant web
page by excluding stop words and do stemming on the documents.
3.3 User Layer
In order to transform patient profiles and data in a knowledge base into usable
and useful knowledge for the dentist, the importance of an user-friendly user layer
cannot be over emphasised. A good interface is also crucial in the technology
diffusion process to enable high acceptance and absorption rates by the users.
In fact, a poorly designed user interface can only reduce the performance and
benefits to clinicians [9], resulting in a barrier against system adoption.
Besides providing the range of drugs whose properties are to be retrieved
and processed by the underlying layers, the other function of this layer is to
present the results back to the dentist on whether the drug in question is safe
for prescription. In this system, the data layer essentially consists of the drug
profile of the patients and the drug which the dentist is going to prescribe. The
user layer also consists of the results after computation of similarity ratio is
completed at the data layer. The result acts as a supporting tool to the dentist
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User Layer Data Layer Knowledge Layer
• Efficient mapping of user
requirements
• Efficient choice
of programming ap-
proach
• Bio medical data sources,
drug taxonomy
• User friendly interface • Implementation of
data mining
• Drug properties
• Algorithm design
Table 1. Features of Conceptual Framework
for decision support. If the drug to be prescribed is found to adversely interact
with the drug that patient is currently taking or is similar to the drug that
patient is allergic to, then it is in this layer that an alternative drug is presented
to the dentist.
As highlighted in Table 1 for the three layers in this framework, user require-
ments in the user layer need to be efficiently mapped onto the data layer to
enable useful and relevant information to be extracted for further computing of
the similarity ratio.
3.4 Feature Extraction
To arrive at a decision as to whether
a drug is suitable for prescription,
a similarity ratio is required as a
measure of how similar they are
in terms of their term frequen-
cies. These term frequencies are ob-
tained after performing data min-
ing on each of the properties of
the drugs associated with “Profes-
sional”, “Overview” and “Side Ef-
fects”. Once the properties of drugs
are known, their term frequencies
are computed. Feature vectors of
tf*idf are then constructed based
on the term frequencies. By deter-
mining the difference between fea-
ture vector of a pair of drugs, the
similarity ratio can be calculated.
If p and q are the feature vectors,
then the cosine similarity is given
by:
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s(p, q) =
k∑
i=1
pi.qi
√
a.b
where a =
k∑
i=1
pi
2 and b =
k∑
i=1
qi
2
As seen in Algorithm 1, this cosine similarity s is computed after gathering the
features within the properties of each drug. Based on the cosine similarity of
each drug pair, average values are computed. With these values as a guide, a
threshold value θ is set to maximise the F measure for each of the drug property.
Section 5 explains the approach in deciding on the threshold value.
For a given drug pair, the similarity ratio taken from each of the three prop-
erties can also be combined and use as a prescription support to check if the
drug to be prescribed is similar to the drug that patient is allergic to. In our
work, equal weights are used to compute the overall similarity ratio. The average
value of θ is also used as a threshold against the overall similarity ratio.
Thus the overall similarity ratio for drug p and drug q is given by:
sim(p, q) = 0.33 ∗ Sv + 0.33 ∗ Sp + 0.33 ∗ Ss where
Sv is the similarity ratio for the drug property from “Overview”
Sp is the similarity ratio for the drug property from “Professional”
Ss is the similarity ratio for the drug property from “Side Effects”
If the similarity ratio exceeds the average threshold value θ, the model will
return a false, indicating that the drug to be prescribed is similar to the drug
that patient is allergic to.
3.5 Preparing Drug Properties
With the URL links to clusters of interactive drugs readily available, the content
of drugs.com website is scanned for information on the cluster of drugs that are
interactive with each entry in the drug taxonomy.
Each web page contains field markers to delimit the relevant content on in-
teractive drugs and these markers are used to extract the cluster of drugs that
adversely interact with each drug in the dataset. Information on the cluster of
adversely interactive drugs is crucial as it provides the ground truth in deciding
whether a drug pair is in an adverse relationship. Such information are contained
in the drug taxonomy T within the knowledge layer of the conceptual frame-
work. Besides mining the information related to clusters of drug interactions for
each drug in the drug taxonomy, the underlying properties for each drug is also
obtained to provide information on the similarity of a drug pair. These proper-
ties are term frequencies tfv, tfp and tfs mined respectively from “Overview”,
“Side Effects” and “Professional” tab of each drug in the drug taxonomy. These
knowledge will then be used to compute the cosine similarity of the drug pair -
refer to Figure 3 for the flow of the experimental design.
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4 Experimental Evaluation
We choose an experimental approach to assess the accuracy and efficiency of the
proposed method. It tests the hypothesis that similar drug pairs have a higher
similarity ratio compared to those dissimilar pairs.
To evaluate the performance of our model, precision, recall and F measure
are adopted in this experiment. Precision indicates how accurately the model
predicts drug pairs as similar, while recall indicates how accurately similar drug
pairs are predicted.
precision =
TP
TP + FP
recall =
TP
TP + FN
(1)
where TP refers to those non-similar pair that are predicted correctly(True Pos-
itive), FN refers to similar pairs predicted incorrectly (False Negative) and FP
refers to non similar pairs predicted incorrectly (False Positive).
Fmeasure =
2 ∗ precision ∗ recall
precision+ recall
(2)
Accuracy is also used to measure the percentage of correct predictions combining
both the similar and dissimilar predictions.
accuracy =
TP + TN
TP + FP + FN + TN
(3)
5 Results and Discussion
With the unique three-tier conceptual framework where knowledge is extracted
from the knowledge base and delivered to the data layer, the result from this
model demonstrates the efficiency and robustness of our model. Not only does
the algorithm is able to compute the similarity of the drug pair, such information
can be adopted as a decision support to health professional in drug prescription.
The prediction is based on the hypothesis that a drug-pair is similar if the cosine
similarity ratio between the frequent patterns are high.
By computing the similarity ratio between drug pairs, their average values
are obtained as a guide to set the threshold θ in order to maximise the F measure.
As shown in Table 2, a range of values for θ are applied for each of the drug
properties “Overview”, “Professional” and “Side Effects”. For example, θ of
0.94 is used as a threshold to compute the recall, precision and F measure for
features gathered from the drug property “Professional” as the maximum value
of F score occurs at this value. Figure 4 shows the recall, precision and F scores
achieved with drug properties gathered from “Overview”, “Professional” and
“Side Effects”.
As indicated in Figure 4, the recall rate of 70% is achieved from drug proper-
ties obtained from “Overview”, showing that our model performed much better
than other methods of prediction. In contrast, the work by [16] achieved 45%
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Fig. 3. Experimental Design
Table 2. F measure at different theta
Fig. 4. Performance Comparison against
Different Drug Properties
with predictions based on drug metabolism. In terms of accuracy, which measures
the percentage of correct predictions combining both the similar and dissimilar
predictions, our system comes out at over 80% compared to 69% where drug
predictions are based on the relationship between drug targets [18].
Drug currently Drug Allergy
taking
Warfarin Amoxicillin
Drug prescribed Drug recommended
Methotrexate Cladribine
Acetaminophen Acetaminophen
Metronidazole -nill-
Table 3. Sample Result of Recom-
mender
To illustrate the conceptual framework of this study, the same model can be
used to decide if the drug is suitable for prescription. Based on the overall simi-
larity (as explained in Section 3.4) from the three properties of the drug pair, the
system can detect if the drug is similar to the drug that patient has allergy. This
approach highlights the usefulness of our framework where knowledge generated
from the data layer can be applied to the user layer and becomes useful to the
user, in this case, as a decision support tool to the health professional. This novel
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way allows us to support the dentist with the right prescription, ensuring the
drug is not in adverse relationship with the drug patient is taking while at the
same time it is not similar to the drug that patient is allergic to, which is the
aim of this study.
For example, for a patient with heart problem consuming Warfarin and is
allergic to Amoxicillin, our model is able to recommend an alternative drug.
In other words, the drug should not be in adverse interaction with Warfarin
and should also not be similar to Amoxicillin. From Table 3, as Methotrexate
is not safe, our model suggests Cladribine as an alternative. However, since
Acetaminophen is safe, nothing new is suggested and there is also the scenario
where the model is unable to recommend any drug from the existing knowledge
base.
6 Conclusions
This paper has presented a novel approach in advising the suitability of a drug
prescription by predicting the similarity of a drug pair. This is different from
conventional prediction of drug interactions. We have applied our model by in-
tegrating the prediction of the drug interaction with the personal medical status
of the patient by taking into consideration the drug that the patient is taking
to avoid adverse interaction and the drug that patient has allergy to avoid cross
allergy. It has also been demonstrated in this research through the experiment
that the three-tier approach adopted in our research design performs well and
thus can readily be implemented within the clinical workflow of a dental clinic.
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